Tech Session VII: Alternative Methods to Animal Testing II
Reconstructed Human Patient Dynamic Models for Engineering Targeted Therapeutics for Aneurysms
Friday, July 18, 2025
8:29 AM – 8:54 AM EDT
Introduction: An aneurysm is an abnormal bulge in a blood vessel wall caused by weakening. Its rupture can lead to a subarachnoid hemorrhage, a life-threatening emergency. Treating unruptured aneurysms with minimally invasive surgeries involve significant risks, when there is no medical treatment available (1-3). Here, we present patient-specific reconstructed models that simulate the biophysical features of high-risk aneurysms, including recirculating blood flow and damaged vessel walls. These models demonstrate the critical differences in designing therapeutic carriers for human vs animal models (4,5).
Learning Objectives:
At the completion of this activity, participants will know
Use of human dynamic cardiovascular disease models for designing localized therapeutics.
Define the differences of drug carriers for cardiovascular diseases between human and animal models.
Leverage biophysical features of human diseases for developing effective drug delivery systems.